 GUANGZHOU, ChinaBUSINESS WIREBio-Thera Solutions, Ltd. SH: 688177, a commercial-stage biopharmaceutical company, announced that the China National Medical Products Administration NMPA has approved BAT1806, a biosimilar of Actemra tocilizumab, in China. BAT1806is the first tocilizumab biosimilar approved by the NMPA or any other regulatory agency around the world and has been approved for the treatment of ...... 